Anoush Costanian
Nurse Practitioner · Englewood, NJNPI 1932827391
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,915 of the $7,710 with a category attached, or 89.7%. It is spread thinly across 35 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $29.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$1K
- Lundbeck LLC$1K
- SK Life Science, Inc.$453
- Eisai Inc.$437
- Otsuka America Pharmaceutical, Inc.$311
- plus $3K from 29 others
What the payments were for
- Consulting fees$79510%
- Food & beverage$6,91590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 74 | $1,348 |
| AbbVie | 51 | $1,282 |
| Lundbeck LLC | 15 | $1,230 |
| SK Life Science, Inc. | 4 | $453 |
| Eisai Inc. | 11 | $437 |
| Otsuka America Pharmaceutical, Inc. | 6 | $311 |
| Neurocrine Biosciences, Inc. | 5 | $301 |
| CSL Behring | 10 | $287 |
| Lilly USA, LLC | 16 | $255 |
| AstraZeneca | 8 | $231 |
| TG Therapeutics, Inc. | 2 | $226 |
| Argenx US, Inc. | 4 | $151 |
| Sanofi | 1 | $120 |
| MDD US Operations, LLC | 1 | $118 |
| UCB, Inc. | 5 | $97 |
| Acadia Pharmaceuticals Inc | 1 | $76 |
| Axsome Therapeutics, Inc. | 5 | $75 |
| Pfizer | 4 | $73 |
| Kyowa Kirin, Inc. | 5 | $72 |
| Harmony Biosciences LLC | 2 | $56 |
| Genentech USA, Inc. | 4 | $52 |
| Azurity Pharmaceuticals, Inc. | 3 | $51 |
| Jazz Pharmaceuticals Inc. | 3 | $49 |
| Biogen | 2 | $46 |
| GE HealthCare | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 3 | $44 |
| Johnson & Johnson | 3 | $43 |
| Merz Pharmaceuticals, LLC | 2 | $37 |
| Neurelis, Inc. | 2 | $34 |
| Corium, LLC | 2 | $33 |
| Insightec,inc | 1 | $17 |
| Life Molecular Imaging Ltd | 1 | $17 |
| Merck | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,710 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $167 |
| Donepezil Hcl | 15 | $111 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Englewood
- Sophia KimEnglewood$70K
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.